Post–hematopoietic cell transplantation (HCT) prophylaxis using cyclophosphamide to stave off graft-vs-host disease had positive results compared with calcineurin inhibitor–based prophylaxis, ...
Erratum: Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147) In a prospective, multicenter phase I/II trial (EudraCT ...
Matched sibling donors (MSD) and matched unrelated donors (MUD) continue to yield the best 2-year survival outcomes following allogeneic hematopoietic cell transplantation (HCT), while mismatched ...
A recent study suggests that patients with myelodysplastic syndrome (MDS) could potentially benefit from allogeneic hematopoietic cell transplantation (HCT) regardless of genetic mutation status.
Credit: Getty Images. The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient or outpatient setting. Each setting is associated with ...
The first fixed-dose combination involving Novartis’first-in-class oral renin inhibitor, Tekturna with hydrochlorothiazide (HCT)was approved in the USin January 2008. A single-tablet combination with ...
Please provide your email address to receive an email when new articles are posted on . Ninety percent of patients with sickle cell disease survived at least 7 years after allogeneic HCT. A majority ...
Olmesartan medoxomil, hydrochlorothiazide; 20mg/12.5mg, 40mg/12.5mg, 40mg/25mg; tabs. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results